Ling‐Yu Chu
Impact in
-
- Cancer-related molecular mechanisms research
Papers in
- Surgery 13
- Esophageal Cancer Research and Treatment 12
-
- Gastric Cancer Management and Outcomes 11
- Co-authors
- Yi‐Wei Xu (26 shared papers)Yu‐Hui Peng (25 shared papers)Jian‐Jun Xie (11 shared papers)Chao‐Qun Hong (15 shared papers)Xinyi Huang (7 shared papers)Yi‐Wei Lin (9 shared papers)Hao Chen (5 shared papers)Biao Zhang (5 shared papers)
In The Last Decade
Ling‐Yu Chu
27 papers receiving 220 citations
Peers
Comparison fields: 5 of 48
- Otorhinolaryngology 20
- Cancer Research 64
- Oncology 85
- Pulmonary and Respiratory Medicine 65
- Surgery 75
Countries citing papers authored by Ling‐Yu Chu
This map shows the geographic impact of Ling‐Yu Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Yu Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Yu Chu more than expected).
Fields of papers citing papers by Ling‐Yu Chu
This network shows the impact of papers produced by Ling‐Yu Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Yu Chu. The network helps show where Ling‐Yu Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling‐Yu Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 53 | |
| 2 | 2019 | 21 | |
| 3 | 2020 | 19 | |
| 4 | 2019 | 16 | |
| 5 | 2021 | 13 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 8 | |
| 8 | 2020 | 8 | |
| 9 | 2020 | 8 | |
| 10 | 2021 | 7 | |
| 11 | 2019 | 6 | |
| 12 | 2024 | 6 | |
| 13 | 2022 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2024 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2020 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2024 | 3 |
About Ling‐Yu Chu
Ling‐Yu Chu is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Cancer Research, having authored 30 papers that have together received 220 indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (12 papers), Gastric Cancer Management and Outcomes (11 papers), Inflammatory Biomarkers in Disease Prognosis (5 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Cancer-related molecular mechanisms research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer-related gene regulation (3 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Otorhinolaryngology (20 citations), Cancer Research (64 citations), Oncology (85 citations), Pulmonary and Respiratory Medicine (65 citations) and Surgery (75 citations). Ling‐Yu Chu has collaborated with scholars based in China and India. Frequent co-authors include Yi‐Wei Xu, Yu‐Hui Peng, Jian‐Jun Xie, Chao‐Qun Hong, Xinyi Huang, Yi‐Wei Lin, Hao Chen, Biao Zhang, Feiran Zhang and Yiteng Huang. Their work appears in journals such as Journal of Cancer, Scientific Reports, Technology in Cancer Research & Treatment, Cancer Management and Research and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.